Skip to main content
SpringerLink
Log in

Graft-versus-tumour effect in refractory metastatic neuroblastoma

  • Letter to the Editor
  • Published:
Bone Marrow Transplantation Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2

References

  1. Champlin R, Khouri I, Shimoni A, Gajewski J, Kornblau S, Molldrem J et al. Harnessing graft-versus-malignancy: non-myeloablative preparative regimens for allogeneic haematopoietic transplantation, an evolving strategy for adoptive immunotherapy. Br J Haematol 2000; 111: 18–29.

    Article  CAS  Google Scholar 

  2. Childs R, Chernoff A, Contentin N, Bahceci E, Schrump D, Leitman S et al. Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 2000; 343: 750–758.

    Article  CAS  Google Scholar 

  3. Kanda Y, Komatsu Y, Akahane M, Kojima S, Asano-Mori Y, Tada M et al. Graft-versus-tumor effect against advanced pancreatic cancer after allogeneic reduced-intensity stem cell transplantation. Transplantation 2005; 79: 821–827.

    Article  Google Scholar 

  4. Tchirkov A, Kanold J, Combaret V, Philip I, Kwiatkowski F, Malet P et al. Immunological and molecular detection of tumor contamination in leukapheresis products from children with disseminated neuroblastoma: implication for evaluation of tumor cell depletion after CD34 selection. Bone Marrow Transplant 1999; 24: 229–230.

    Article  CAS  Google Scholar 

  5. Reynolds CP . Detection and treatment of minimal residual disease in high-risk neuroblastoma. Pediatr Transplant 2004; 8 (Suppl 5): 56–66.

    Article  Google Scholar 

  6. Steinmetz HT, Schulz A, Staib P, Scheid C, Glasmacher A, Neufang A et al. Phase-II trial of idarubicin, fludarabine, cytosine arabinoside, and filgrastim (Ida-FLAG) for treatment of refractory, relapsed, and secondary AML. Ann Hematol 1999; 78: 418–425.

    Article  CAS  Google Scholar 

  7. Fleischhack G, Hasan C, Graf N, Mann G, Bode U . IDA-FLAG (idarubicin, fludarabine, cytarabine, G-CSF), an effective remission-induction therapy for poor-prognosis AML of childhood prior to allogeneic or autologous bone marrow transplantation: experiences of a phase II trial. Br J Haematol 1998; 102: 647–655.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Centre Hospitalier et Universitaire de Clermont-Ferrand, Service de Pédiatrie B et Unité Bioclinique de Thérapie Cellulaire, Clermont-Ferrand, France

    A Marabelle, C Paillard, P Halle, F Deméocq & J Kanold

  2. Faculté de Médecine, Université Clermont1, Clermont-Ferrand, France

    A Marabelle, A Tchirkov, P Halle, F Deméocq & J Kanold

  3. INSERM, CIC501, Clermont-Ferrand, France

    A Marabelle, C Paillard, P Halle, F Deméocq & J Kanold

  4. Laboratoire d'immunologie, Centre Jean Perrin, Clermont-Ferrand, France

    A Tchirkov & J Chassagne

Authors
  1. A Marabelle
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C Paillard
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A Tchirkov
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. P Halle
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. J Chassagne
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. F Deméocq
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. J Kanold
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Marabelle.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Marabelle, A., Paillard, C., Tchirkov, A. et al. Graft-versus-tumour effect in refractory metastatic neuroblastoma. Bone Marrow Transplant 39, 809–810 (2007). https://doi.org/10.1038/sj.bmt.1705681

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1705681

  • Springer Nature Limited

This article is cited by

Search

Navigation